Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Blend · Columbia Threadneedle

Columbia Acorn Fund Columbia Acorn Fund Class C (LIACX)

Ticker LIACX · Since 2000-10-16 · · Holdings as of Jun 30, 2026

Expense ratio
1.83%$183/yr per $10k
5-yr return
+0.1%annualized
1-yr return
+2.8%as of Dec 2025
Net assets
$2.8Ball share classes
Holdings
95

Bottom line

Is LIACX a good fund? The bottom line

LIACX is a share class of Columbia Acorn Fund, a managed large blend mutual fund from Columbia Threadneedle.

Annual fees run 1.83% — about $183 a year on every $10,000 invested, more expensive than 90% of large blend funds we track.

It returned +2.8% over one year, +0.1% a year over five years, +7.5% a year over ten (as of Dec 31, 2025, per its prospectus).

With $2.8 billion in net assets and 95 holdings, its largest position is Columbia Short Term Cash Fund (5.5%) and the top 10 make up 23.2% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.83%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What LIACX invests in

Columbia Acorn Fund (the Fund) seeks long-term capital appreciation.

Under normal circumstances, the Fund invests a majority of its net assets in the common stock of small- and mid-sized companies. These companies have market capitalizations in the range of companies in the Russell 2500 Growth Index (the Capitalization Index), which ranged between $4.4 million and $50.2 billion as of March 31, 2026. The market capitalization range and composition of companies in the Capitalization Index are subject to change. The Fund invests the majority of its assets in U.S. companies, but also may invest up to 33% of its total assets in foreign companies in developed markets (for example, Japan, Canada and the United Kingdom) and in emerging markets (for example, China, India and Brazil). The Fund may at times emphasize one or more sectors in selecting its investments, including the health care, industrials, and information technology sectors.

From the fund's prospectus (filed Apr 23, 2026).

LIACX performance

Average annual total returns
1 yr5 yr10 yr
LIACX+2.8%+0.1%+7.5%
Large Blend median+13.8%+9.7%+10.9%

Source: Fund prospectus, as of Dec 31, 2025

Full LIACX performance history →

What LIACX costs

On a $10,000 investment, LIACX's 1.83% expense ratio costs about $183 a year. The prospectus estimates $1,971 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.

See the full LIACX fee table →

LIACX top 10 holdings

#Holding% of fund
1Columbia Short Term Cash Fund5.54%
2SPX Technologies Inc2.78%
3VSE Corp2.08%
4GCM Grosvenor Inc2.00%
5SharkNinja Inc1.90%
6Cavco Industries Inc1.85%
7DigitalOcean Holdings Inc1.81%
8Guardant Health Inc1.79%
9Rush Street Interactive Inc1.75%
10Viavi Solutions Inc1.72%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 23.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to LIACX

More funds like LIACX →

LIACX FAQ

What is the expense ratio of LIACX?
LIACX's expense ratio is 1.83%, which works out to about $183 a year for every $10,000 invested. The prospectus estimates total costs of $1,971 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is LIACX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.83%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does LIACX hold?
LIACX's largest holdings are Columbia Short Term Cash Fund (5.5%), SPX Technologies Inc (2.8%), VSE Corp (2.1%), GCM Grosvenor Inc (2.0%), SharkNinja Inc (1.9%). It holds 95 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is LIACX's 5-year return?
LIACX returned +0.1% a year over the five years ending Dec 31, 2025, and +7.5% a year over ten years. Past performance does not guarantee future results.
Does LIACX have a sales load?
No. LIACX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages LIACX?
LIACX is offered by Columbia Threadneedle through Columbia Acorn Trust.